135 related articles for article (PubMed ID: 8301115)
1. Tissue-specific expression of messenger RNAs encoding endogenous viral superantigens.
Jarvis CD; Germain RN; Hager GL; Damschroder M; Matis LA
J Immunol; 1994 Feb; 152(3):1032-8. PubMed ID: 8301115
[TBL] [Abstract][Full Text] [Related]
2. Exogenous mouse mammary tumor virus (MMTV) infection induces endogenous MMTV sag expression.
Xu L; Wrona TJ; Dudley JP
Virology; 1996 Jan; 215(2):113-23. PubMed ID: 8560758
[TBL] [Abstract][Full Text] [Related]
3. Control of endogenous mouse mammary tumor virus superantigen expression in SJL lymphomas by a promoter within the env region.
Zhang DJ; Tsiagbe VK; Huang C; Thorbecke GJ
J Immunol; 1996 Oct; 157(8):3510-7. PubMed ID: 8871650
[TBL] [Abstract][Full Text] [Related]
4. Strain-specific expression of spliced MMTV RNAs containing the superantigen gene.
Xu L; Wrona TJ; Dudley JP
Virology; 1997 Sep; 236(1):54-65. PubMed ID: 9299617
[TBL] [Abstract][Full Text] [Related]
5. Expression of two structurally identical viral superantigens results in thymic elimination at distinct developmental stages.
Morishima C; Norby-Slycord C; McConnell KR; Finch RJ; Nelson AJ; Farr AG; Pullen AM
J Immunol; 1994 Dec; 153(11):5091-103. PubMed ID: 7963568
[TBL] [Abstract][Full Text] [Related]
6. Delay in expression of a mammary tumor provirus is responsible for defective clonal deletion during postnatal period.
Niimi N; Wajjwalku W; Ando Y; Tomida S; Takeuchi M; Ueda M; Kaneda T; Yoshikai Y
Eur J Immunol; 1994 Feb; 24(2):488-91. PubMed ID: 8299700
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of endogenous mouse mammary tumor virus superantigen expression by lymphocyte subsets.
Waanders GA; Lees RK; Held W; MacDonald HR
Eur J Immunol; 1995 Sep; 25(9):2632-7. PubMed ID: 7589137
[TBL] [Abstract][Full Text] [Related]
8. A V beta 8.2-specific superantigen from exogenous mouse mammary tumor virus carried by FM mice.
Yoshimoto T; Nagase H; Nakano H; Matsuzawa A; Nariuchi H
Eur J Immunol; 1994 Jul; 24(7):1612-9. PubMed ID: 7913038
[TBL] [Abstract][Full Text] [Related]
9. A superantigen encoded in the open reading frame of the 3' long terminal repeat of mouse mammary tumour virus.
Choi Y; Kappler JW; Marrack P
Nature; 1991 Mar; 350(6315):203-7. PubMed ID: 1706480
[TBL] [Abstract][Full Text] [Related]
10. Expression of Mtv-7 sag gene in vivo using a retroviral vector results in selective inactivation of superantigen reactive T cells.
Kang J; Ido E; Pawling J; Beutner U; Huber BT; Hozumi N
J Immunol; 1994 Feb; 152(3):1039-46. PubMed ID: 8301116
[TBL] [Abstract][Full Text] [Related]
11. Expression and presentation of endogenous mouse mammary tumor virus superantigens by thymic and splenic dendritic cells and B cells.
Ardavín C; Waanders G; Ferrero I; Anjuère F; Acha-Orbea H; MacDonald HR
J Immunol; 1996 Oct; 157(7):2789-94. PubMed ID: 8816381
[TBL] [Abstract][Full Text] [Related]
12. Mouse mammary tumor virus superantigens require N-linked glycosylation for effective presentation to T cells.
McMahon CW; Bogatzki LY; Pullen AM
Virology; 1997 Feb; 228(2):161-70. PubMed ID: 9123822
[TBL] [Abstract][Full Text] [Related]
13. Identification of two V beta 7-specific viral superantigens.
Ignatowicz L; Kappler JW; Marrack P; Scherer MT
J Immunol; 1994 Jan; 152(1):65-71. PubMed ID: 8254207
[TBL] [Abstract][Full Text] [Related]
14. Mouse mammary tumor virus superantigen expression is reduced by glucocorticoid treatment.
Tovar Sepúlveda VA; Berdel B; Coffin JM; Reuss FU
Virology; 2000 Sep; 275(1):98-106. PubMed ID: 11017791
[TBL] [Abstract][Full Text] [Related]
15. A mouse mammary tumor virus-like long terminal repeat superantigen in human breast cancer.
Wang Y; Jiang JD; Xu D; Li Y; Qu C; Holland JF; Pogo BG
Cancer Res; 2004 Jun; 64(12):4105-11. PubMed ID: 15205319
[TBL] [Abstract][Full Text] [Related]
16. Detection of retroviral superantigen and products of the envelope gene from endogenous mouse mammary tumor virus in B cells from BALB/c mice.
Lopez-Cepero M; Wang Y; Keydar I; Brandt-Carlson C; Butel JS; Lopez DM
Cell Immunol; 1995 Jul; 163(2):191-7. PubMed ID: 7606792
[TBL] [Abstract][Full Text] [Related]
17. Deletion of peripheral V beta 14+ T cells by Mtv-2-encoded viral superantigen preceded by blastogenesis and DNA synthesis but not by specific expansion.
Nakano H; Yoshimoto T; Nariuchi H; Kakiuchi T; Matsuzawa A
Cell Immunol; 1996 Mar; 168(2):281-90. PubMed ID: 8640876
[TBL] [Abstract][Full Text] [Related]
18. Transposon-mediated random insertions and site-directed mutagenesis prevent the trafficking of a mouse mammary tumor virus superantigen.
McMahon CW; Traxler B; Grigg ME; Pullen AM
Virology; 1998 Apr; 243(2):354-65. PubMed ID: 9568034
[TBL] [Abstract][Full Text] [Related]
19. Endogenous superantigen expression controlled by a novel promoter in the MMTV long terminal repeat.
Günzburg WH; Heinemann F; Wintersperger S; Miethke T; Wagner H; Erfle V; Salmons B
Nature; 1993 Jul; 364(6433):154-8. PubMed ID: 8391646
[TBL] [Abstract][Full Text] [Related]
20. B and T cells are required for mouse mammary tumor virus spread within the mammary gland.
Golovkina TV; Dudley JP; Ross SR
J Immunol; 1998 Sep; 161(5):2375-82. PubMed ID: 9725233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]